Wednesday, 16 April 2014

Propagating the Science of Alzheimers through Michael Mullan Led Roskamp Institute


Few people persevere in their dedication to find solutions for particular diseases and the number further decreases in medical science. There are very few discoveries besides the ones conducted by large pharmaceutical companies. But, Michael Mullan has proved beyond any reasonable doubt that dedication doesn’t match to the name and fame one acquires in the field of human disease research. It has been more than four decades now as a neuroscientist that Michael Mullan has become a known figure in the entire world for his research on neurological diseases, concentrating primarily on Alzheimer’s disease.




Respectable stint as CEO of Roskamp Institute in Florida

After having completed his masters in medicine and being a teaching faculty in different institutes in London, Dr Michael Mullan focussed on research in neuroscience. For this purpose, he went to Sarasota in Florida to become the CEO of Roskamp Institute this city of America. In this place, he has now been over a decade and in his 70s, Dr Mullan is working consistently towards the molecular biogenetics of Alzheimer and various other neurological afflictions. He focuses on the neurodegenerative changes in these conditions and is aiming to find out solutions to prevent the occurrence of amyloidal deposits in the brain cells, leading to Alzheimer and Parkinson diseases.

Sending message across to scientific communities through research journals

In all these years, he has published more than 200 research articles and papers about the neurological damages and possible therapies towards the prevention and cure of Alzheimer’s. With a competent and highly qualified group of scientists and post-doctoral students in Roskamp in Sarasota, Dr Mullan has found many breakthrough experiments and researches on this topic. His credibility as a neuroscientist led him to be appointed the CEO of Roskamp Institute in Florida and he has been in the leading front for more than a decade now.

Highly revered opinions provided by Dr Mullan on neurodegenerative diseases

During these times, he has been able to place his opinions backed by well researched reasoning about the pathological and neurological changes inside the brain in cases of Alzheimer’s. After studying the molecular changes in the brains of affected individuals, he has given a number of lectures and seminars to prove his point among the think tank of the world. His point of view has also been enthusiastically received by the medical and scientific fraternity all over the globe. His videos and lectures are nowadays used in different research organisations. Still, Michael Mullan persists with his breakthrough studies in finding possible solutions towards finding drugs and unique ways to stop these diseases from occurring.

Taking further steps into the research world by encouraging others

Although the research journals and articles have created awareness among people about Alzheimer’s diseases, he is currently bringing out his theories in the online world, so that common men and women start realising about the disease. He has provided various assumptions and research data on the way of life to prevent this disease from occurring. His work has further inspired more upcoming research scientists to join the bandwagon at Sarasota, Florida and carry on the good work being done in Roskamp Institute.

For More Details Visit Here: -- Michael Mullan Sarasota

Tuesday, 11 March 2014

Enrich Your Knowledge about Michael Mullan and Alzheimer’s Disease

There are certain great researchers that have given substantial knowledge regarding the most perilous diseases to the world. Among these a very prominent name that comes immediately to one’s mind is that of Michael Mullan. He is a well known scientist and researcher in the fields of molecular genetics and dementia. He is a renowned personality in the zone of neurosciences and has number of research papers authored by him.




Gaining an insight into the life of Michael Mullan

Michael Mullan acquired training as a physician in England obtaining his medical degree from London University. Then he completed PhD in Molecular Genetics from the same university. He was the author of the research papers illustrating the genetic disorders that cause early onset Alzheimer’s disease. He has co-written over more than 200 papers on this disease and its associated disorders. He is currently serving as the CEO and President of Roskamp Institute which is financially aided by several agencies including Department of Defense, National Institutes of Health (NIH), etc. He along with a group of neuroscientists at the Roskamp Institute has invented a Brain Reserve Index that is used to determine the risk of developing this disease of Alzheimer. He is also the President of Sci-Brain that incorporates a new concept of ameliorating the brain fitness owing to the relationships between physical and mental health using Brain or cognitive reserve.

Learn about the Roskamp Institute of Florida

This institute is located at Michael Mullan Sarasota in Florida. It is these days testing Nilvadipine, a medical drug which is claimed to cure early onset of the disease of Alzheimer. This is an anti-hyper intensive drug and is considered as a potential treatment for this disease. The founder of this institution is Bob Roskamp. It is dedicated towards researching for cure to neurologically degenerative diseases. Moreover, funding is provided here towards incurable diseases such as HIV and cancer. Along with Dr. Mullan, this institute is also contributing towards finding out cures and preventive treatment methods for such diseases.

Recently, Dr. Mullan at this institute proclaimed to the students and other people in the audience that the basic or major causes for dementia are hypertension, diabetes, cardiac diseases, etc. He further emphasized to implement a proper regulatory and balanced diet in your regime to maintain good health as well as prevent yourself against this extremely perilous disease.

Important Aspects of Alzheimer’s disease

Alzheimer’s disease occurs in a human brain due to several causes. It shows different symptoms at every new stage. At the early stage the common symptom is short term memory loss. As one further move with this ailment he would find sudden mood swings and get irritated easily and quickly. Gradually, all body organs stop operating and it ultimately leads to death. Although, till now viable medication has been found to cure this ailment yet the risks of acquiring it can be minimized by various means such as playing memory games, eating green vegetables, consuming large amount of water and milk, etc.

It can be deduced from above that Dr. Mullan has made a remarkable contribution in the area of neurological diseases and their treatment methods. He has completely devoted his life to the research in the field of mutation, molecular genetics and ailments concerning brain. He is really very intelligent and at the same time extremely amicable personality.

For More Details Visit Here: -- Michael Mullan Florida

Wednesday, 12 February 2014

Roskamp Institute and its Work on Finding a Cure for Alzheimer’s Disease


Alzheimer’s disease is considered one of the banes of old age. This crippling medical condition afflicts hundreds and thousands of people globally. While there is no known cure available for the condition, it can be treated and people can be helped to lead as normal a life as possible. While a lot of research is being carried on in finding a cure for the disease, one particular research institution is considered a pioneer in the field. The Roskamp Institute located in Sarasota, Florida has been doing extensive research in the field.

The person who has been behind the institute’s fight against Alzheimer has been Dr.Michael Mullan. The President and CEO of the institute, Michael Mullan is a name that is well known throughout the medical world. He leads a team of research scientists in the institute. They have been able to come out with some major breakthroughs. Research findings from this team are used by other research institutions around the world.

One of the focus areas of the research at the Roskamp Institute has been to stop the onset of the disease. Dr.Michael Mullan and his team have done extensive research on the different types of triggers for the onset of the disease. They have also been able to come out with findings on the type of diet that can help stop the onset of the disease. Research findings from the team have found that a balanced diet that contains plenty of antioxidants is one of the best ways to stop the onset of the disease. A diet that contains whole grains, and lots of fresh fruits and vegetables is what has been recommended in order to prevent the onset of this dreaded disease.
The research done at the institution has found that certain lifestyle modifications can also help in stopping the onset of the disease. It has found for example, that other lifestyle connected medical conditions such as diabetes or high blood pressure could sometimes be the trigger for Alzheimer’s disease. The research at the Roskamp Institute has also led to the finding that there are certain types of proteins whose formation may be linked to Alzheimer’s disease. These research findings are considered pioneering by those in the medical field. They are referred to in finding a cure for a variety of mental illnesses by research institutions globally.
When it comes to research on mental illnesses, Michael Mullan is considered an authority. He has headed scores of research initiatives. He has been the man behind hundreds of research papers, which are among the most sought after by the medical fraternity who are researching on the topic of mental illnesses. As the CEO and President of the Roskamp Institute, Dr.Michael Mullan has also been successful in spreading awareness about Alzheimer’s disease and the various treatment methods available throughout the world.
For More Details Visit Here:-- Alzheimer

Tuesday, 14 January 2014

Alzheimer’s disease – Treatment Approaches That Work


Thousands of people around the world suffer from the crippling effects of Alzheimer’s disease. This is a disorder where the part of the brain that controls memory is affected. Several research institutions around the world are trying their best to find a cure to this disease. Michael Mullan has been a pioneer in this field. His research on the dreaded disease is well known throughout the world.

The identification of a certain protein that has got a direct relation to the onset of the disease has been a significant discovery of Dr. Michael Mullan. A biomedical researcher, Dr.Mullan is considered an authority when it comes to research on mental disorders. His career started after he received his medical degree from the London University. He trained as a physician in England. He has completed his PhD in molecular genetics, again from the London University. He has been the key figure behind over 200 papers on Alzheimer’s disease. At present, as the CEO and President of The Roskamp Institute, located in Sarasota, Florida, he is further continuing his crusade against this debilitating disorder.



One of the significant findings of the researchers at The Roskamp Institute is that of the “Brain Reserve Index”. Using this index the researchers are able to indicate the risk of developing Alzheimer’s disease in a person. Dr. Mullan’s research papers are much sought after by the medical community around the world.

Apart from the work that is being done by Dr. Mullan, there are other research institutions around the world which also have been trying to find a cure to the disease. While significant breakthroughs have been made, there is no known cure for Alzheimer’s disease till now. The disease is known to becoming increasingly progressive as a person ages. A group of drugs known as “cholinesterase inhibitors” are usually used for treating the condition. What these drugs do is to moderate the symptoms. In certain cases, doctors also recommend anti-psychotic medicines for people suffering from the disease.

The team under Dr. Mullan at Sarasota, Florida has also done a lot of research on the link between diet and the onset of Alzheimer’s disease. Accordingly they have figured out that certain types of diet are beneficial in preventing the onset of the disease in the first place. A well balanced diet that consists of plenty of fresh fruits and vegetables to provide all the necessary vitamins and minerals has been recommended to tackle the menace of Alzheimer’s disease.



Thursday, 12 December 2013

Well Known Researcher Calls for More Studies on Alzheimer’s Disease


 
There are a few diseases that have puzzled medical researchers for long and one of them is Alzheimer’s Disease. According to conservative estimates, more than 36 million people across the globe suffer from this disease. As a matter of fact, there is growing concern about this disease which tends to mostly affect elderly people given that populations of many countries are aging rapidly. This is sure to put a lot of pressure on public health care systems in many countries while also resulting in societal problems unless a vaccine or a cure for it can be found.

According to widely famed scientist and biomedical researcher Dr.Micheal Mullen, one of the biggest problems is that this disease does not get the attention that it deserves even though it poses huge problems. As President and CEO of the Roskamp Institute which is located in Sarasota Florida, he leads a team of dedicated researchers who have been at the forefront of the research to understand this disease. He certainly knows what he is talking about when he says that the disease needs to be understood better. Dr. Mullen, a physician trained in London, is also a renowned geneticist who has published many papers on Alzheimer’s and other long term degenerative diseases that affect the brain.

One of the biggest problems faced by Alzheimer’s researchers is the serious lack of funding. This has got something to do with the fact that trials for this disease take inordinately long. It is an unfortunate fact that the cost of the trials goes up in direct proportion to the time it takes. In fact, there are at least a hundred trails for cancer for every trial conducted for Alzheimer's disease. Besides, clinical trials for this disease are not easy to conduct.



Another factor to be considered is that most research on Alzheimer’s focuses on the levels of a protein called Amyloid in late stage Alzheimer’s patients. It is the accumulation of this protein in the brain which is known to cause the onset of the disease. However, since very little research studies its levels at the early stages or even before the onset of the disease, there is still very little understanding of the disease. Michael Mullan has maintained that this small but significant protein merits further study as do other early markers of Alzheimer’s disease.

There is absolutely no doubt about the fact that the Alzheimer’s research community is woefully underfunded. It is only when it gets government and private funding in the required quantum that researchers will be able to get plenty of breakthroughs about this disease. In the meanwhile, physicians and researchers alike eagerly await the results of studies conducted at places like the Roskamp Institute.